Literature DB >> 28084903

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population.

Pär Hallberg1, Matilda Persson1, Tomas Axelsson2, Marco Cavalli3, Pia Norling4, Hans-Erik Johansson5, Qun-Ying Yue6, Patrik Ke Magnusson7, Claes Wadelius3, Niclas Eriksson8, Mia Wadelius1.   

Abstract

AIM: We conducted a genome-wide association study on angiotensin-converting enzyme inhibitor-induced cough and used our dataset to replicate candidate genes identified in previous studies. PATIENTS &
METHODS: A total of 124 patients and 1345 treated controls were genotyped using Illumina arrays. The genome-wide significance level was set to p < 5 × 10-8.
RESULTS: We identified nearly genome-wide significant associations in CLASP1, PDE11A, KCNMB2, TGFA, SLC38A6 and MMP16. The strongest association was with rs62151109 in CLASP1 (odds ratio: 3.97; p = 9.44 × 10-8). All top hits except two were located in intronic or noncoding DNA regions. None of the candidate genes were significantly associated in our study.
CONCLUSION: Angiotensin-converting enzyme inhibitor-induced cough is potentially associated with genes that are independent of bradykinin pathways.

Entities:  

Keywords:  angiotensin converting enzyme inhibitors; bradykinin; cough; drug-related side effects and adverse reactions; enalapril; genome-wide association study; lisinopril; pharmacogenetics; quinapril; ramipril

Mesh:

Substances:

Year:  2017        PMID: 28084903     DOI: 10.2217/pgs-2016-0184

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  7 in total

Review 1.  WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19.

Authors:  Philip W Rouadi; Samar A Idriss; Jean Bousquet; Tanya M Laidlaw; Cecilio R Azar; Mona S Al-Ahmad; Anahi Yañez; Maryam Ali Y Al-Nesf; Talal M Nsouli; Sami L Bahna; Eliane Abou-Jaoude; Fares H Zaitoun; Usamah M Hadi; Peter W Hellings; Glenis K Scadding; Peter K Smith; Mario Morais-Almeida; René Maximiliano Gómez; Sandra N Gonzalez Diaz; Ludger Klimek; Georges S Juvelekian; Moussa A Riachy; Giorgio Walter Canonica; David Peden; Gary W K Wong; James Sublett; Jonathan A Bernstein; Lianglu Wang; Luciana K Tanno; Manana Chikhladze; Michael Levin; Yoon-Seok Chang; Bryan L Martin; Luis Caraballo; Adnan Custovic; Jose Antonio Ortego-Martell; Olivia J Ly Lesslar; Erika Jensen-Jarolim; Motohiro Ebisawa; Alessandro Fiocchi; Ignacio J Ansotegui
Journal:  World Allergy Organ J       Date:  2022-05-14       Impact factor: 5.516

Review 2.  Hypertension genomics and cardiovascular prevention.

Authors:  Fu Liang Ng; Helen R Warren; Mark J Caulfield
Journal:  Ann Transl Med       Date:  2018-08

3.  Demographic and Clinical Characteristics of Patients Presenting With Angiotensin-converting Enzyme Inhibitors Induced Cough.

Authors:  Fatima Jamshed; Hassam Jaffry; Hamza Hanif; Vinesh Kumar; Uruja Naz; Mehak Ahmed; Sundus Fareed
Journal:  Cureus       Date:  2019-09-11

4.  Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery.

Authors:  Chan Joo Lee; Bogeum Choi; Hayeon Pak; Jung Mi Park; Ji Hyun Lee; Sang-Hak Lee
Journal:  Yonsei Med J       Date:  2022-04       Impact factor: 2.759

Review 5.  Drug-Induced Cough.

Authors:  J-S Shim; W-J Song; A H Morice
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

6.  Characteristics of Chronic Cough in adults in Pakistani population: A cross sectional study.

Authors:  Kaleem Ullah Toori; Asma Chaudhry
Journal:  Pak J Med Sci       Date:  2020 Mar-Apr       Impact factor: 1.088

7.  Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.

Authors:  Eva Rye Rasmussen; Pär Hallberg; Ekaterina V Baranova; Niclas Eriksson; Malgorzata Karawajczyk; Caroline Johansson; Marco Cavalli; Cyrielle Maroteau; Abirami Veluchamy; Gunilla Islander; Svante Hugosson; Ingrid Terreehorst; Folkert W Asselbergs; Pia Norling; Hans-Erik Johansson; Hugo Kohnke; Ann-Christine Syvänen; Moneeza K Siddiqui; Chim C Lang; Patrik K E Magnusson; Qun-Ying Yue; Claes Wadelius; Christian von Buchwald; Anette Bygum; Ana Alfirevic; Anke H Maitland-van der Zee; Colin N A Palmer; Mia Wadelius
Journal:  Pharmacogenomics J       Date:  2020-02-21       Impact factor: 3.550

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.